文献速递其他结缔组织病

抗合成酶综合征纵向队列研究:黑人及抗PL7/抗PL12抗体患者间质性肺病更重

A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.
PubMed 文献 · Rheumatology (Oxford) · 2017-01-01

结果显示抗PL7和抗PL12与更 prevalent 且严重的肺部受累相关,常无肌肉受累;抗Jo1与更严重肌肉受累相关;黑人患者肺部受累更严重,独立于抗体状态;病死率与肿瘤风险较一般美国人群无显著增加。

要点

  • 抗PL7和抗PL12抗体与更严重肺部受累相关,常无肌肉受累。
  • 抗Jo1抗体与更严重肌肉受累相关,且更常合并抗Ro52抗体。
  • 黑人患者肺部受累更严重,独立于抗合成酶抗体状态。

核心结论

  • 不同抗合成酶抗体对应表型不同的亚组,抗PL7和抗PL12以更严重肺部受累为特征,抗Jo1以更严重肌肉受累为特征,黑人种族是肺部疾病严重程度的重要预后因素。

研究设计与样本

  • 研究为约翰霍普金斯肌炎纵向队列研究,纳入所有抗合成酶综合征抗体阳性的受试者,前瞻性收集症状、体征、肌力、肌酸激酶浓度和肺功能测试等临床信息。

主要发现

  • 抗PL12在黑人受试者中更常见,抗PL12和抗PL7与更 prevalent 且严重的肺部受累相关,常无肌肉受累。
  • 抗Jo1患者肌肉受累较抗PL12患者更严重,合并抗Ro52更 prevalent 且与更早出现机械手、DM特异性皮肤表现和关节炎相关。
  • 独立于抗合成酶抗体状态,黑人患者肺部受累较白人患者更严重。
  • 抗合成酶综合征患者病死率或肿瘤风险较一般美国人群无显著增加。

临床怎么用

  • 对怀疑抗合成酶综合征的患者应检测包括抗PL7和抗PL12在内的抗体谱,以识别肺部受累风险更高的亚组。
  • 黑人患者即使抗体状态不同,也应警惕更严重的肺部受累,加强间质性肺病评估与监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim was to study the prevalence, rate of appearance and severity of clinical features in patients with different anti-synthetase syndrome (ASyS) autoantibodies. METHODS: All Johns Hopkins Myositis Longitudinal Cohort subjects positive for any ASyS autoantibodies were included. Clinical information, including symptoms, signs, strength, creatine kinase concentrations and pulmonary function tests, were prospectively collected. The standardized mortality and cancer rates and the rate of appearance and intensity of the different organ manifestations were assessed using univariate and multivariate analysis and compared between ASyS autoantibodies. RESULTS: One hundred and twenty-four (73.4%) patients were positive for anti-Jo1, 23 (13.6%) for anti-PL12, 16 for anti-PL7 (9.5%) and 3 (1.8%) for anti-EJ or anti-OJ, respectively. The mean length of follow-up was 4.1 years. Anti-PL12 was more frequent in black subjects. Anti-PL12 and anti-PL7 were associated with more prevalent and severe lung involvement, often without muscle involvement. Anti-Jo1 displayed more severe muscle involvement compared with anti-PL12 patients. Concurrent anti-Ro52 was more prevalent in anti-Jo1 patients and was associated with earlier development of mechanic's hands, DM-specific skin findings and arthritis. Independent of ASyS antibody status, black patients demonstrated more severe lung involvement than white patients. There was no significant increase in mortality or cancer risk in ASyS patients compared with the general US population. CONCLUSION: Different ASyS autoantibodies are associated with phenotypically distinct subgroups within the ASyS spectrum. Anti-PL7 and anti-PL12 are characterized by more severe lung involvement, whereas anti-Jo1 is associated with more severe muscle involvement. Black race is a major prognostic factor associated with lung disease severity.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Pinal-Fernandez I, Casal-Dominguez M, Huapaya JA, et al. A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies. Rheumatology (Oxford). 2017. PMID: 28339994. doi:10.1093/rheumatology/kex021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。